Cancer pathways. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells Lymph Nodes Epithelial Cells Neoplastic Cells, Circulating Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases57

Neoplasms Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Disease Progression Colorectal Neoplasms Rectal Neoplasms Neoplasm Recurrence, Local Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Head and Neck Neoplasms Liver Neoplasms Adenocarcinoma Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Genital Neoplasms, Female Precancerous Conditions Skin Neoplasms Gastrointestinal Neoplasms Thyroid Neoplasms Mammary Neoplasms, Experimental Pharyngeal Neoplasms Neoplasms, Multiple Primary Kidney Neoplasms Melanoma Neoplastic Syndromes, Hereditary Carcinoma, Lobular Breast Neoplasms, Male Disease Models, Animal Occupational Diseases Neoplasms, Experimental Testicular Neoplasms Carcinoma in Situ Neoplastic Cells, Circulating Carcinoma, Pancreatic Ductal Carcinoma, Intraductal, Noninfiltrating Papillomavirus Infections Adenoma

Chemicals and Drugs54

Cancer Vaccines Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen Tumor Markers, Biological RNA, Messenger Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Fluorouracil Tamoxifen Cisplatin Receptors, Progesterone Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Antigens, Neoplasm Anticarcinogenic Agents Paclitaxel Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Antibodies, Monoclonal Deoxycytidine Antimetabolites, Antineoplastic Receptors, Androgen Taxoids RNA, Neoplasm DNA-Binding Proteins BRCA2 Protein Androgens Proto-Oncogene Proteins Antibodies, Monoclonal, Humanized Transcription Factors BRCA1 Protein Carcinogens Nuclear Proteins Estrogens Proto-Oncogene Proteins c-akt Protein Kinase Inhibitors Estrogen Receptor alpha Quinazolines Androgen Antagonists Carcinoembryonic Antigen Organoplatinum Compounds Antibiotics, Antineoplastic Protein-Serine-Threonine Kinases Cadherins beta Catenin DNA Primers Camptothecin Proto-Oncogene Proteins c-bcl-2 Enzyme Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Gene Expression Profiling Early Detection of Cancer Survival Analysis Survival Rate Prognosis Antineoplastic Combined Chemotherapy Protocols Risk Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Retrospective Studies Registries Xenograft Model Antitumor Assays Prospective Studies Neoplasm Staging Risk Assessment Neoplasm Transplantation Disease-Free Survival Combined Modality Therapy Blotting, Western Odds Ratio Chemotherapy, Adjuvant Transplantation, Heterologous Sensitivity and Specificity Mammography Multivariate Analysis Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Risk Factors Questionnaires Tumor Burden SEER Program Drug Screening Assays, Antitumor Molecular Targeted Therapy Clinical Trials as Topic Polymerase Chain Reaction Transfection Predictive Value of Tests Logistic Models Reproducibility of Results Radiotherapy Neoplasm Grading Tissue Array Analysis Confidence Intervals Models, Biological Gene Knockdown Techniques Flow Cytometry Incidence Mammary Neoplasms, Experimental Drug Administration Schedule Immunoenzyme Techniques Palliative Care Mastectomy Treatment Outcome Biopsy Immunotherapy Genetic Testing Radiotherapy, Adjuvant DNA Mutational Analysis Prostatectomy Colonoscopy Drug Delivery Systems Disease Models, Animal Neoplasms, Experimental Immunohistochemistry Genetic Therapy Real-Time Polymerase Chain Reaction Lymph Node Excision Radiotherapy Dosage

Psychiatry and Psychology1

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Signal Transduction Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Mutation Odds Ratio DNA Methylation Cell Survival Sensitivity and Specificity Genotype Cell Movement Genes, BRCA1 Down-Regulation Cell Division Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Cell Proliferation Cell Growth Processes Apoptosis Promoter Regions, Genetic RNA Interference Transfection Up-Regulation Gene Silencing Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Genes, p53 Postmenopause Diet Genes, BRCA2 Base Sequence Gene Expression Phenotype Phosphorylation Epithelial-Mesenchymal Transition Alleles Drug Synergism Tumor Microenvironment Epigenesis, Genetic Menopause Premenopause CpG Islands Loss of Heterozygosity DNA Damage Genes, ras Gene Amplification Transcription, Genetic

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires SEER Program Base Sequence Incidence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care31

Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Risk Assessment Disease-Free Survival Odds Ratio Age Factors Sensitivity and Specificity Multivariate Analysis Kaplan-Meier Estimate Risk Factors Questionnaires SEER Program Clinical Trials as Topic American Cancer Society Predictive Value of Tests Logistic Models Reproducibility of Results Confidence Intervals Incidence Palliative Care Treatment Outcome Genetic Testing Age Distribution Occupational Exposure Confounding Factors (Epidemiology)

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Gene Expression Regulation, Neoplastic Neoplasms Gene Expression Profiling Signal Transduction Early Detection of Cancer Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Mice, Nude Cancer Vaccines Neoplasm Proteins Uterine Cervical Neoplasms Survival Analysis Genetic Predisposition to Disease Survival Rate Prognosis Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Carcinoma Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell National Cancer Institute (U.S.)Disease Progression Risk Reverse Transcriptase Polymerase Chain Reaction Follow-Up Studies Cell Line, Tumor Colorectal Neoplasms Retrospective Studies Receptors, Estrogen Registries Xenograft Model Antitumor Assays Tumor Markers, Biological Prospective Studies Mutation Neoplasm Staging RNA, Messenger Survivors Receptor, erbB-2 Risk Assessment United States Rectal Neoplasms Neoplasm Recurrence, Local Neoplasm Transplantation Disease-Free Survival Combined Modality Therapy Prostate-Specific Antigen DNA, Neoplasm Blotting, Western Cell Transformation, Neoplastic Endometrial Neoplasms Odds Ratio Age Factors RNA, Small Interfering DNA Methylation Smoking Chemotherapy, Adjuvant Tumor Suppressor Protein p53 Esophageal Neoplasms Fluorouracil Cell Survival Tamoxifen Medical Oncology Transplantation, Heterologous Neoplastic Stem Cells Sensitivity and Specificity Cisplatin Receptors, Progesterone Antineoplastic Agents, Phytogenic Genotype Cell Movement Genes, BRCA1 Mammography Antineoplastic Agents, Hormonal Down-Regulation Antigens, Neoplasm Multivariate Analysis Breast Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Risk Factors Questionnaires Tumor Burden SEER Program Drug Screening Assays, Antitumor Head and Neck Neoplasms Liver Neoplasms Cell Division Anticarcinogenic Agents Adenocarcinoma Mouth Neoplasms Neoplasms, Hormone-Dependent

No FAQ available that match "cancer pathways"